Mikhail Blagosklonny is a passionate scientist who wanted to be credited as the first man to discover the key to immortal life. Dr. Mikhail Blagosklonny is a graduate of the First Pavlov State Medical University of St. Petersburg, where he earned his MD and PhD titles. He became an oncology professor at the Roswell Park Cancer Institute, and this is where his fascination with immortal life began. As a professor teaching about the nature of cancers, he discovered that a substance called rapamycin produces two centric models that can be used to rejuvenate the cells and strengthen the body’s immunity. He initially thought that it can be used to “cure” aging, and so he decided to work on a number of researches to discover the potential of rapamycin.Ancient civilizations have myths and legends about gods, goddesses and supernatural humans bearing the ability to live forever. Dr. Mikhail Blagosklonny is fascinated by these stories, and hopes to bring it into reality. However, he is aware of the possible consequences of his action, and he is very cautious about the possible abuse of the research that he is working on. He wanted to make sure that if ever the key to immortality will be discovered in his lifetime, it will be used ethically and will be protected from selfish interests.
According to the research of Dr. Mikhail Blagosklonny, rapamycin’s two centric models have the ability to rejuvenate cells – in short, they can create new, younger cells that will replace the degenerated ones in just a short span of time. It means that for every degenerating cell that dies, tens or even hundreds of new ones replace it. These centric models also have the capability to strengthen the immune system. This means that old and new diseases, even if they mutate, could no longer harm the body easily because of the innovation that the centric models have introduced. The pathogens must evolve further into their most advanced forms in order to harm humans. These centric models are divided into two, and they are named the TOR and the MTOR model. These centric models can be found through a variety of ways: first one would be via genetics, where in a parent who has the TOR and the MTOR centric models on their DNA could pass it to their offspring.
Another way to obtain these is from degenerative cells which has undergone rejuvenation. The new, younger cells have a higher chance of bearing a TOR or MTOR centric model. The final way to obtain them is through the extraction of the TOR or MTOR centric model in diseases, such as Alzheimer’s and Parkinson’s disease.The potential of this research is high, and it could drive humans into another age, making fictional scientific discoveries like space travel possible. When Dr. Mikhail Blagosklonny initially presented his research on a group of scientists, they labeled it as ridiculous and impossible. However, after presenting additional evidences and success in his research, the scientists who once mocked Dr. Mikhail Blagosklonny are slowly taking their words back, as they also saw that the idea could be introduced in real life. Other pharmaceutical companies have taken note of the research made by Dr. Mikhail Blagosklonny, and they are also using all their resources to find a way on how to cure aging and live forever.
Eric Lefkofsky is an American entrepreneur who is most noted as the co-founder and chairman of the popular e-commerce website Groupon. He grew up in Michigan where he attended school and eventually went on to earn a degree. Continue reading to learn more about Eric Lefkofsky’s educational background as well as his many different business endeavors.
Eric Lefkofsky began his educational career at the Southfield-Lathrup High School back in 1983. The school was located in Lathrup, Michigan close to his childhood home. He graduated from high school in 1987 before moving on to college.
Eric Lefkofsky attended the University of Michigan which is one of the most popular schools in the country and is located in Ann Arbor, Michigan. They currently have over 40,000 students and are known for their many amazing sports teams. Lefkofsky graduated from the University of Michigan in 1991 with high honors.
After attending and graduating from the University of Michigan Eric Lefkofsky then went on to continue his education at the University of Michigan law school also located in Ann Arbor, Michigan. The school was established cancer resource in 1859 and offers some of the top programs in the world. Eric Lefkofsky graduated from the University of Michigan law school in 1993 after receiving his Juris doctor. A Juris doctor also known as a doctor of jurisprudence is a graduate entry professional degree in law and one of many different doctor of law degrees.
Eric Lefkofsky has been involved in many different health care business endeavors over the years. These are just a few of the many titles and roles he has held since graduating from the University of Michigan law school.
Tempus is a unique and innovative approach to cancer. It is a technology company that is helping to build the world’s largest library of molecular and clinical data. It is a new and improved way of offering personalized care to each individual patient using genetic coding and other technology advanced data.
These are just a few of the many different business endeavors that Eric Lefkofsky has been involved in over the years. He’s also heavily involved in many different charities and is constantly working to improve the world.
When many people come to Cancer Treatment Centers of America® (CTCA), they are looking for a solution that meets their unique needs. CTCA is a specialized health care company that operates with a philosophy that each patient is unique, and deserves a comprehensive approach to their treatment, that takes not only their own unique health issues in mind but also relies on the most recent cancer treatment data.
That’s why CTCA has partnered with NantHealth and Allscripts to create a custom solution while helping eviti®, another NantHealth clinical decision support solution, to access clinical workflows in the Allscripts Sunrise electronic health record.
What does this mean in a practical, everyday sense? Treatment decisions will come faster. The Clinical Pathways program helps inform the cancer treatment process, without interrupting the physician’s clinical workflow, providing a clinical decision support solution that is both practical and cutting-edge.
The project to improve the workflow came from a practical source as well: A network of hundreds of oncologists across the US. The direct interface of the clinical operating system (NantOS) was crowds ourced and built with their input. With this expertise, Cancer Treatment Centers of America has access to a comprehensive collection of cancer data to use for critical clinical decisions. Click here to learn more about CTCA.
Every cancer is as unique as the person fighting it, and that’s why fighting cancer requires truly personalized care, delivered by experts trained in the complexities of a difficult disease. This data will help doctors at CTCA continue to offer the best medical care to their clients, based on the most recent data in the field.